NCT00654043View on ClinicalTrials.gov

Bioavailability Study of Torsemide Tablets Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

May 31, 2001

Study Completion Date

May 31, 2001

Conditions
Healthy
Interventions
DRUG

Torsemide

tablets, 20 Mg, single-dose

DRUG

Demadex

Tablets, 20 mg, single-dose

Sponsors

Collaborators (1)

Anapharm
All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00654043 - Bioavailability Study of Torsemide Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter